In this study (Figure 7), we found that UBE2T is overexpressed at both the mRNA and protein levels in patient-derived breast cancer samples, and UBE2T overexpression predicted poor survival among patients with breast cancer. This evidence concerns the gene UBE2T and breast carcinoma.